Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Mind Medicine Inc.
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
August 13, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 06, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
August 06, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
July 29, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
July 17, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 21, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Participate in June Conferences
May 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
October 24, 2023
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.